BlackRock’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19M Buy
1,021,851
+735,258
+257% +$12.2M ﹤0.01% 3114
2025
Q4
$3.78M Buy
286,593
+161,212
+129% +$1.9M ﹤0.01% 3930
2025
Q3
$899K Sell
125,381
-201,961
-62% -$10.5M ﹤0.01% 4312
2025
Q2
$15.5M Buy
327,342
+41,133
+14% +$1.68M ﹤0.01% 3164
2025
Q1
$11.2M Sell
286,209
-82,636
-22% -$3.56M ﹤0.01% 3262
2024
Q4
$20M Sell
368,845
-31,940
-8% -$1.63M ﹤0.01% 3059
2024
Q3
$20.2M Buy
400,785
+8,761
+2% +$411K ﹤0.01% 3037
2024
Q2
$17.2M Sell
392,024
-16,256
-4% -$689K ﹤0.01% 3071
2024
Q1
$20.5M Buy
408,280
+26,554
+7% +$1.44M ﹤0.01% 2985
2023
Q4
$23.1M Sell
381,726
-367,152
-49% -$18.9M ﹤0.01% 2934
2023
Q3
$42.7M Buy
748,878
+91,344
+14% +$5.04M ﹤0.01% 2491
2023
Q2
$33.5M Buy
657,534
+542,604
+472% +$14.6M ﹤0.01% 2724
2023
Q1
$2.46M Sell
114,930
-626,828
-85% -$10.5M ﹤0.01% 3955
2022
Q4
$7.79M Sell
741,758
-74
-0% -$658 ﹤0.01% 3507
2022
Q3
$5.76M Sell
741,832
-74
-0% -$523 ﹤0.01% 3694
2022
Q2
$3.9M Hold
741,906
﹤0.01% 3936
2022
Q1
$8.24M Hold
741,906
﹤0.01% 3683
2021
Q4
$7.34M Sell
741,906
-5,957
-0.8% -$59.2K ﹤0.01% 3833
2021
Q3
$7.37M Hold
747,863
﹤0.01% 3809
2021
Q2
$7.74M Sell
747,863
-2,290
-0.3% -$23.3K ﹤0.01% 3737
2021
Q1
$7.66M Hold
750,153
﹤0.01% 3726
2020
Q4
$8.53M Buy
+750,153
New +$7.96M ﹤0.01% 3450

Other funds holding MLTX